Related Experiment Video
Updated: Aug 12, 2025
08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
10.4K
Changes in Coagulation Study and Risk of Developing Cholesteatoma: Is There a Link?
Joana Raquel Costa1, Ângela Reis Rego1, Teresa Soares1
1Department of Otorhinolaryngology-Head and Neck Surgery, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Journal of Audiology & Otology
|January 30, 2023
Summary
Pediatric cholesteatoma may be linked to subtle coagulation factor changes. Slightly prolonged partial thromboplastin times in children may influence angiogenesis and cholesteatoma development.
Area of Science:
- Otolaryngology
- Pediatric Medicine
- Molecular Biology
Background:
- The exact cause of acquired pediatric cholesteatoma remains unclear.
- Research is exploring molecular-level explanations, including the role of coagulation factors.
- This study investigates the connection between coagulation and cholesteatoma pathogenesis.
Purpose of the Study:
- To determine if coagulation factor dysfunctions are associated with acquired pediatric cholesteatoma.
- To explore the potential role of coagulation in cholesteatoma-related angiogenesis.
Main Methods:
- A retrospective case-control study was conducted.
- 92 children were included, comparing those with and without cholesteatoma.
- Coagulation parameters (partial thromboplastin time, prothrombin time, INR) were analyzed.
Main Results:
- Partial thromboplastin times were observed to be higher in children with cholesteatoma.
- A statistically significant difference in normal versus abnormal partial thromboplastin times was found (p=0.029).
Conclusions:
- Slightly prolonged partial thromboplastin times may indicate molecular-level implications for cholesteatoma.
- These findings suggest a potential role for coagulation in activating angiogenesis and growth factors.
- This could be relevant to the onset, growth, and expansion of acquired pediatric cholesteatoma.
